Integrin Alpha10 Patent for Aggressive Cancer Treatment

Sat, 18 Apr 2026 03:29:10 +0000
Intellectual Property

The European Patent Office published patent application EP3956360A1 for Integrin Alpha10 compositions and methods for treating aggressive cancer forms. Applicant Targinta AB seeks protection across 37 designated European states. The patent covers anti-integrin alpha10 antibodies and therapeutic applications for cancer treatment.